RSM conducted the financial due diligence for ProductLife Group during the acquisition of Stragen Services

RSM, the 6th largest global network of consulting and audit firms, conducted the financial due diligence for ProductLife Group (PLG), a regulatory consulting company for life sciences, during the acquisition of Stragen Services, a European platform in the field of specialized generics.

ProductLife Group was supported by an RSM team under the supervision of Eric Fougedoire, RSM partner.

ProductLife Group renews its trust in the RSM teams to support its external growth operations and international ventures.

Through this new operation, RSM demonstrates its expertise in regulatory consulting by supporting leading players in the life sciences sector.

Press Release from ProductLife Group

ProductLife Group (PLG), a global provider of regulatory, science, compliance, and digital transformation services for the life sciences industry, is pleased to announce the acquisition of Stragen Services, a division of the Stragen Group, a well-established European platform in the field of specialized generics, supported by the international private equity fund ARCHIMED, specialized in the healthcare sector.

Founded in 2009 and based in Lyon, France, Stragen Services is a recognized partner of pharmaceutical and biotechnology communities in the fields of pharmacovigilance and clinical safety. With a team of 35 employees, Stragen Services has built a strong reputation for its expertise and tailored pharmacovigilance services. By integrating Stragen Services, PLG strengthens its position in these key areas, supporting its ongoing goal to ensure access, compliance, and safety of products in international markets.

Stéphane Collomb Gilbert, Managing Director of Stragen Services, stated: “Joining PLG represents a strategic and exciting step for Stragen Services, our teams, and our clients. PLG’s commitment to excellence, integrity, and client-focused partnerships perfectly reflects our values. This alliance enhances our ability to provide top-tier international safety solutions and to better support our clients through PLG’s integrated global infrastructure. With the growing demand for innovation and global expertise, we look forward to expanding our reach and making an even greater impact together.”

Xavier Duburcq, CEO of PLG, emphasized: “We are excited to welcome Stragen Services to the PLG family. This acquisition marks a key step in our growth journey, consolidating our position as a leader in pharmacovigilance in the French and European markets. It reflects our commitment to providing our clients with world-class support, ensuring their products meet the highest standards of safety and compliance in an increasingly complex global environment. The expertise and track record of Stragen Services will play a crucial role in strengthening our position in the industry and fully align with our ambitions.”

Jean-Yves Desmottes, Partner at ARCHIMED, commented: “Originally created to support the pharmacovigilance activities of the Stragen Group, Stragen Services has evolved over the past 15 years, expanding its expertise and offering its services to many external clients. PLG presents an excellent opportunity for all its employees to continue this trajectory, maintain the highest standards of excellence, expand the service offering, and ultimately support the next phase of growth.”